14 Results for "

ILK

" in MedChemExpress (MCE) Product Catalog:
Products (14)

14 Results for "ILK" in MCE Product Catalog:

12
12 Publications Verification
Cat. No.: HY-18676
CAS No.: 2070015-22-2
Research Areas:  

Cancer

OSU-T315 (ILK-IN-1) is a small Integrin-linked kinase (ILK) inhibitor with an IC50 of 0.6 μM, inhibiting PI3K/AKT signaling by dephosphorylation of AKT-Ser473 and other ILK targets (GSK-3β and myosin light chain) . OSU-T315 abrogates AKT activation by impeding AKT localization in lipid rafts and triggers caspase-dependent apoptosis in an ILK-independent manner . OSU-T315 causes cell death through apoptosis and autophagy .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-113439
CAS No.: 71030-37-0
Purity:  95.70%
Category:  

Microorganisms

Target:  

Apoptosis

12-HETE, a major metabolic product of arachidonic acid using 12-LOX catalysis, inhibits cell apoptosis in a dose-dependent manner. 12-HETE promotes the activation and nuclear translocation of NF-κB through the integrin-linked kinase (ILK) pathway .12-HETE has both anti-thrombotic and pro-thrombotic effects . 12-HETE is a neuromodulator .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-113439S
CAS No.: 2525175-25-9
Purity:  ≥98.0%
12-HETE-d8 is the deuterium labeled 12-HETE. 12-HETE, a major metabolic product of arachidonic acid using 12-LOX catalysis, inhibits cell apoptosis in a dose-dependent manner. 12-HETE promotes the activation and nuclear translocation of NF-κB through the integrin-linked kinase (ILK) pathway .12-HETE has both anti-thrombotic and pro-thrombotic effects . 12-HETE is a neuromodulator .
loading...
    loading...
Cat. No.: HY-115677
CAS No.: 6975-75-3
Purity:  99.62%
Target:  

Ser/Thr Kinase

Research Areas:  

Cancer

ILK-IN-3 is an orally active integrin linked kinase (ILK) inhibitor. ILK-IN-3 improves the anticancer efficacy of Docetaxel (HY-B0011) in orthotopic LCC6 model .
loading...
    loading...
Cat. No.: HY-18676B
CAS No.: 1333146-24-9
Synonyms: OSU-T315 analog
Research Areas:  

Cancer

ILK-IN-2 (OSU-T315 analog) is an oral PDK2 inhibitor and also an ILK inhibitor, with an IC50 of 0.6 μM. ILK-IN-2 induces cell autophagy and apoptosis, showing anti-tumor activity. ILK-IN-2 directly abolishes AKT activation by preventing AKT from translocating to lipid rafts, triggering Caspase-dependent apoptosis in chronic lymphocytic leukemia (CLL) and extending the lifespan in TCL1 mouse models .
loading...
    loading...
Cat. No.: HY-P4866
CAS No.: 1361235-89-3
Q-Peptide is an angiopoietin-1 derived peptide (QHREDGS). Q-Peptide interacts with β1-integrin, binds to integrins on the surface of osteoblasts, and serves as an acyl donor substrate for Streptomyces mobaraensis transglutaminase. Q-Peptide activates Akt, MAPKp42/44, ILK, ERK1/2, and downregulates caspase-3/7. Q-Peptide inhibits cell apoptosis, enhances cell adhesion and migration, and promotes osteoblast differentiation, bone matrix deposition and mineralization. Q-Peptide can be used in studies related to myocardial infarction, bone regeneration, diabetic wound repair and human induced pluripotent stem cells .
loading...
    loading...
Cat. No.: HY-RS06787
Research Areas:  

Others

ILK Human Pre-designed siRNA Set A contains three designed siRNAs for ILK gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS23195
Research Areas:  

Others

Ilk Rat Pre-designed siRNA Set A contains three designed siRNAs for Ilk gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-177912
CAS No.: 1333146-87-4
Target:  

Ser/Thr Kinase

Research Areas:  

Cancer

ILK-IN-4 (compound 49) is an integrin-linked kinase (ILK) inhibitor. ILK-IN-4 can be used for cancer research .
loading...
    loading...
Cat. No.: HY-RS16756
Research Areas:  

Others

Ilk Mouse Pre-designed siRNA Set A contains three designed siRNAs for Ilk gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-P83366
Synonyms: ILK; ILK1; ILK2; Integrin-linked protein kinase; 59 kDa serine/threonine-protein kinase; ILK-1; ILK-2; p59ILK

Host:  

Rabbit

Application:  

WB, IP

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Cat. No.: HY-P83366A
Synonyms: ILK; ILK1; ILK2; Integrin-linked protein kinase; 59 kDa serine/threonine-protein kinase; ILK-1; ILK-2; p59ILK

Host:  

Rabbit

Application:  

WB, IP

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Cat. No.: HY-184113
Synonyms: DHP
Target:  

Integrin Arp2/3 Complex

Research Areas:  

Cancer

Dihydropelitinib (DHP) is a ILK ligand with a Kd value of 252 nM. Dihydropelitinib acts as a cytoskeleton modulator that induces actin (Actin) cytoskeleton rearrangement. Dihydropelitinib exhibits anticancer activity against liver cancer and lung adenocarcinoma. Dihydropelitinib can be used in studies related to liver cancer and lung adenocarcinoma .
loading...
    loading...
Cat. No.: HY-P87803

Host:  

Rabbit

Application:  

WB, IHC-P, ICC/IF, IP, ELISA

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
  • 1